Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIM0811 in Acute Ischemic Stroke
NCT07903701Phase 3Not yet recruiting
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Nov 2026
- Primary completion
- Jun 2029
01
Overview
A Phase 3 trial of SIM0811 in ischemic stroke, sponsored by Simcere Pharmaceutical Group. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
SIM0811
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07903701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07903701.